EGEN, Inc. Announces That Phase II Clinical Trial For Advanced Ovarian Cancer Is Open For Enrollment

Links shared publicly online about this topic.

  • 653
    total visits

EGEN, Inc. Announces That Phase II Clinical Trial For Advanced Ovarian Cancer Is Open For Enrollment

medicalnewstoday.com —

EGEN, Inc. announced that the first Phase II clinical trial utilizing EGEN-001 for the treatment of recurrent ovarian cancer is now open for enrollment. The trial is sponsored by the Gynecologic

View full resource at medicalnewstoday.com

Tags: Cancer, Ovarian Cancer, Clinical Trial, Women's Health

  • Share

Most Recently Shared on December 17, 2010 at 12:55 am By:

OvarianCancer_ Ovarian Cancer OW

EGEN, Inc. Announces That Phase II Clinical Trial For Advanced Ovarian Cancer Is Open For Enrollment: EGEN, Inc.... http://bit.ly/ielzRL

1 year ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Ovarian Cancer MNT Ovarian Cancer

MNT Clinical Trials MNT Clinical Trials

MNT Pharma News MNT Pharma News

Advertisement